110 related articles for article (PubMed ID: 38193235)
1. Notoginsenoside Fc alleviates oxidized low-density lipoprotein-induced endothelial cell dysfunction and upregulates PPAR-γ in vitro.
Zhang Y; Liu K; Wang D
Histol Histopathol; 2023 Dec; ():18694. PubMed ID: 38193235
[TBL] [Abstract][Full Text] [Related]
2. Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPAR-γ signaling based on network pharmacology and experimental validation.
Zhang B; Hao Z; Zhou W; Zhang S; Sun M; Li H; Hou N; Jing C; Zhao M
Bioengineered; 2021 Dec; 12(1):4887-4898. PubMed ID: 34369277
[TBL] [Abstract][Full Text] [Related]
3. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis.
Zhao J; Cui L; Sun J; Xie Z; Zhang L; Ding Z; Quan X
Cell Signal; 2020 Dec; 76():109781. PubMed ID: 32947021
[TBL] [Abstract][Full Text] [Related]
4. Interference with lysophosphatidic acid receptor 5 ameliorates oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury by inactivating NOD-like receptor family, pyrin domain containing 3 inflammasome signaling.
Xu L; Xu C; Lin X; Lu H; Cai Y
Bioengineered; 2021 Dec; 12(1):8089-8099. PubMed ID: 34662522
[TBL] [Abstract][Full Text] [Related]
5. [Protective effect of Huaxia shallot preparation on human umbilical vein endothelial cell injury induced by oxidized low density lipoprotein and its mechanism].
Zhang JM; Guo J; Tu X; Shi ZH; Hao JJ; Ke YH; Guan JF; He JJ
Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):675-80. PubMed ID: 17997945
[TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.
Zhu L; Gong X; Gong J; Xuan Y; Fu T; Ni S; Xu L; Ji N
Braz J Med Biol Res; 2020; 53(6):e9346. PubMed ID: 32401923
[TBL] [Abstract][Full Text] [Related]
7. Circ_0003423 Alleviates Oxidized Low-Density Lipoprotein-Induced Endothelial Cell Injury by Sponging miR-142-3p and Activating Sirtuin 3/Superoxide Dismutase 2 Pathway.
Wang P; Zhang H; Wang Y
J Surg Res; 2022 Sep; 277():384-397. PubMed ID: 35580464
[TBL] [Abstract][Full Text] [Related]
8. Protein disulfide-isomerase A3 knockdown attenuates oxidized low-density lipoprotein-induced oxidative stress, inflammation and endothelial dysfunction in human umbilical vein endothelial cells by downregulating activating transcription factor 2.
Jia J; Wang Y; Huang R; Du F; Shen X; Yang Q; Li J
Bioengineered; 2022 Jan; 13(1):1436-1446. PubMed ID: 34983301
[TBL] [Abstract][Full Text] [Related]
9. PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4.
Fei X; Cen X; Zhao R; Wang J; Cui H
Int Immunopharmacol; 2023 Sep; 122():110529. PubMed ID: 37399609
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol alleviates human endothelial cell injury through circNOL12/miR-6873-3p/FRS2 axis.
Li S; Hao M; Wu T; Wang Z; Wang X; Zhang J; Zhang L
Biomed Pharmacother; 2021 May; 137():111419. PubMed ID: 33761622
[TBL] [Abstract][Full Text] [Related]
11. Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis.
Zhang C; Wang L; Shen Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):207. PubMed ID: 33892646
[TBL] [Abstract][Full Text] [Related]
12. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress.
Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S
Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: Circulating RNAs could explain atherosclerosis disease progression.
Su Q; Dong X; Tang C; Wei X; Hao Y; Wu J
Open Med (Wars); 2021; 16(1):558-569. PubMed ID: 33869778
[TBL] [Abstract][Full Text] [Related]
14. FOXP1‑induced DUSP12 alleviates vascular endothelial cell inflammation and oxidative stress injury induced by ox‑LDL via MAP3K5 signaling pathway.
Li Y; Gu L; Zhou J; Han C; Zang W
Exp Ther Med; 2023 Sep; 26(3):450. PubMed ID: 37614418
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0004831 downregulation is partially responsible for atorvastatinalleviated human umbilical vein endothelial cell injuries induced by ox-LDL through targeting the miR-182-5p/CXCL12 axis.
Su G; Sun G; Lv J; Zhang W; Liu H; Tang Y; Su H
BMC Cardiovasc Disord; 2021 May; 21(1):221. PubMed ID: 33932991
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-301a-3p increases oxidative stress, inflammation and apoptosis in ox-LDL-induced HUVECs by targeting KLF7.
Jiang H; Lv J
Exp Ther Med; 2021 Jun; 21(6):569. PubMed ID: 33850541
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against oxidized low-density lipoprotein-induced injury in human umbilical vein endothelial cells via the histone deacetylase 9 (HDAC9)/NF-κB axis.
Chen D; Du Y; Ye S; Yu J
Environ Toxicol; 2023 Mar; 38(3):534-544. PubMed ID: 36322813
[TBL] [Abstract][Full Text] [Related]
18. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132.
Fu C; Yin D; Nie H; Sun D
Cell Physiol Biochem; 2018; 51(4):1739-1750. PubMed ID: 30504696
[TBL] [Abstract][Full Text] [Related]
19. Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway.
Zhu Z; Li J; Zhang X
BMC Complement Altern Med; 2019 May; 19(1):111. PubMed ID: 31146723
[TBL] [Abstract][Full Text] [Related]
20. TRIM59 attenuates ox-LDL-induced endothelial cell inflammation, apoptosis, and monocyte adhesion through AnxA2.
Zeng Q; Xie J; Li F
Ann Transl Med; 2023 Jan; 11(2):42. PubMed ID: 36819529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
